Preparation and in vitro study of hydrochloric norvancomycin encapsulated poly (d,l-lactide-co-glycolide, PLGA) microspheres for potential use in osteomyelitis

References

• Akbarzadeh A, Rezaei-Sadabady R, Davaran S, Joo SW, Zarghami N, Hanifehpour Y, et al. 2013. Liposome: classification, preparation, and applications. Nanoscale Res Lett. 8:102.
   PubMed Web of Science ®Google Scholar
• Bao-lin L. 2009. Clinical analysis of norvancomycin hydrochloride for injection on methicillin resistant staphylococcus aureus infection [J]. Chinese J Hospital Pharm. 2:022.
   Google Scholar
• Bevin CR, I C, Keller EE. 2008. Surgical management of primary chronic osteomyelitis: a long-term retrospective analysis. J Oral Maxillofac Surg. 66:2073–2085.
   PubMed Web of Science ®Google Scholar
• Conterno LO, Turchi MD. 2009. Antibiotics for treating chronic osteomyelitis in adults. Cochrane Database Syst Rev. 8:CD004439.
   Google Scholar
• del Valle LJ, Roca D, Franco L, Puiggali J, Rodriguez-Galan A. 2011. Preparation and release study of ibuprofen-loaded porous matrices of a biodegradable poly(ester amide) derived from L-alanine units. J Appl Polym Sci. 122:1953–1967.
   Web of Science ®Google Scholar
• Dunn RL, Ottenbrite RM. Eds. 1991. Polymeric Drugs and Drug Delivery System. ACS Symposium Series. USA: American Chemical Society.
   Google Scholar
• Ebrahimi E, Akbarzadeh A, Abbasi E, Khandaghi AA, Abasalizadeh F, Davaran S. 2016. Novel drug delivery system based on doxorubicin-encapsulated magnetic nanoparticles modified with PLGA-PEG1000 copolymer. Artif Cells Nanomed Biotechnol. 44:290–297.
   PubMed Web of Science ®Google Scholar
• Gavini E, Chetoni P, Cossu M, Alvarez MG, Saettone MF, Giunchedi P. 2004. PLGA microspheres for the ocular delivery of a peptide drug, vancomycin using emulsification/spray-drying as the preparation method: in vitro/in vivo studies. Eur J Pharm Biopharm. 57:207–212.
   PubMed Web of Science ®Google Scholar
• Géze A, Venier-Julienne M-C, Saulnier P, Varlet P, Daumas-Duport C, Devauchelle P, Benoit J-P. 1999. Modulated release of IdUrd from poly (d, l-lactide-co-glycolide) microspheres by addition of poly (d, l-lactide) oligomers. J Control Release. 58:311–322.
   PubMed Web of Science ®Google Scholar
• Gupta P, Johnson H, Allexon C. 1993. In vitro and in vivo evaluation of clarithromycin/poly (lactic acid) microspheres for intramuscular drug delivery. J Control Release. 26:229–238.
   Web of Science ®Google Scholar
• Jain RA. 2000. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials. 21:2475–2490.
   PubMed Web of Science ®Google Scholar
• Ji Y, ping Xu G, peng Zhang Z, jun Xia J, long Yan J, ha Pan S. 2010. BMP-2/PLGA delayed-release microspheres composite graft, selection of bone particulate diameters, and prevention of aseptic inflammation for bone tissue engineering. Ann Biomed Eng. 38:632–639.
   PubMed Web of Science ®Google Scholar
• Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, et al. 2007. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA. 298:1763–1771.
   PubMed Web of Science ®Google Scholar
• Makadia HK, Siegel SJ. 2011. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers. 3:1377–1397.
   PubMed Web of Science ®Google Scholar
• Mediavilla JR, Chen L, Mathema B, Kreiswirth BN. 2012. Global epidemiology of community-associated methicillin resistant Staphylococcus aureus (CA-MRSA). Curr Opin Microbiol. 15:588–595.
   PubMed Web of Science ®Google Scholar
• National Committee for Clinical Laboratory Standards (NCCLS). 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically-Fifth edition. Available from:
   Google Scholar
• Nazarpak MH, Pourasgari F, Sarbolouki M. 2011. Preparation of a novel porous scaffold from poly(lactic-co-glycolic acid)/hydroxyapatite. Asian Biomed. 5:513–518.
   Web of Science ®Google Scholar
• Panagiotis M. 2005. Classification of nonunion. Injury Int Care Injured. 365:30–37.
   Web of Science ®Google Scholar
• Shaobing Z, Xianmo D, Xiaohong L, Wenxiang J, Li L. 2004. Synthesis and characterization of biodegradable low molecular weight aliphatic polyesters and their use in protein-delivery systems. J Appl Polym Sci. 91:1848–1856.
   Web of Science ®Google Scholar
• Simamora P, Chern W. 2006. Poly-L-lactic acid: an overview. J Drugs Dermatol. 5:436–440.
   PubMed Web of Science ®Google Scholar
• Tabatabaei Mirakabad FS, Akbarzadeh A, Milani M, Zarghami N, Taheri-Anganeh M, Zeighamian V, Badrzadeh F, Rahmati-Yamchi M. 2016. A comparison between the cytotoxic effects of pure curcumin and curcumin-loaded PLGA-PEG nanoparticles on the MCF-7 human breast cancer cell line. Artif Cells Nanomed Biotechnol. 44:423–430.
   PubMed Web of Science ®Google Scholar
• Tlougan BE, P J, O’Haver J, Cordova KB, Nguyen XH, Tee R, et al. 2009. Chronic recurrent multifocal osteomyelitis (CRMO)and synovitis,acne,pustulosis,hyperostosis,and osteitis(SAPHO)syndrome with associated neutrophilic dermatoses: a report of seven cases and review of the literature. Pediatr Dermatol. 26:497–505.
   PubMed Web of Science ®Google Scholar
• van de Belt H, Neut D, Schenk W, van Horn JR, van der Mei HC, Busscher HJ. 2000. Gentamicin release from polymethylmethacrylate bone cements and Staphylococcus aureus biofilm formation. Acta Orthopaedica Scandinavica. 71:625–629.
   PubMedGoogle Scholar
• Walencka E, Sadowska B, Rózalska S, Hryniewicz W, Rózalska B. 2006. Staphylococcus aureus biofilm as a target for single or repeated doses of oxacillin, vancomycin, linezolid and/or lysostaphin. Folia Microbiol (Praha). 51:381–386.
   PubMed Web of Science ®Google Scholar
• Wang M, Feng Q, Guo X, She Z, Tan R. 2011. A dual microsphere based on PLGA and chitosan for delivering the oligopeptide derived from BMP-2. Polym Degrad Stabil. 96:107–113.
   Web of Science ®Google Scholar